HAI Prevention Iasis Molecular Sciences develops self-disinfecting antimicrobial solutions to prevent surface-transmitted infections, especially device-related and healthcare-associated infections; this creates collaboration opportunities with medical device manufacturers and hospital-supply companies looking to reduce HAIs.

Medical Device Coatings Target medical device manufacturers and coating developers to embed antimicrobial properties into implants, catheters, and surgical tools, aligning with hospital infection control goals and potential regulatory incentives.

Cross-Sector Expansion Beyond healthcare, the technology applies to consumer products, textiles, coatings, and industrial surfaces, presenting opportunities for licensing, white labeling, or partnerships that broaden the addressable market.

Strategic Partnerships As a small team, pursuing strategic partnerships with contract manufacturers, distributors, or larger bioscience firms can accelerate scale, manufacturing reach, and revenue through joint development or channel deals.

Tech and Validation The tech stack supporting AWS and modern web platforms enables scalable data management, traceability, and regulatory documentation for customers requiring robust pilots and evidence of antimicrobial effectiveness.